International Journal of Drug Regulatory Affairs (IJDRA)
IJDRA is an international, Open-access and peer-reviewed Journal circulated electronically since March, 2013 via the world wide web. It is the first Journal for Drug Regulatory Affairs in India and it publishes Research articles, Review articles, and Case studies on all aspects of Drug Regulatory Affairs, Intellectual Property Rights and Pharmaceutical Development. The journal serves researchers from academia and industry and intended to be of interest to a broad audience of pharmaceutical professionals.
Journal ISSN: [Online ISSN: 2321-6794, Print ISSN: 2321-7162]
Publishing Frequency: Quarterly (4 issues in year)
Submission Type: Online Submission
Copyright License Type: Creative Common Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Index Copernicus International (ICV Value): 81.15 points (2016)
Metadata & DOI (doi.org/10.22270/ijdra): From Crossref-Digital Object Identifier Registration Agency.
Journal Indexing: IJDRA Indexed in more than 90 Databases (Highest in subject), See Indexing
Publishing System: Open Journal SystemS (OJS) by Public knowledge Project.
1500 INR/article from Indian Authors
USD 30/article from Authors from Low-Income Countries.
USD 40/article from Authors from Low-Middle Income Countries.
USD 60/article from Authors from Upper-Middle-Income Countries
USD 100/article from Authors from High-Income Countries.
(No other hidden charges) More detail for waiver policy.
Upcoming Issue: Vol. 6, Issue 4 Oct-Dec, 2018. (Last date for Manuscript submission: 31 Nov, 2018)
Why publish in International Journal of Drug Regulatory Affairs?
- A broad ranging open access journal
- Fast and efficient online submission
- Rapid publication and High visibility
- Constructive rapid & Expert peer review
- Archiving of your article in various international repositories
- Our journal is indexed in various international indexing authorities
- "Certificate of publication" to the authors of accepted articles (On Demand)
IJDRA Publishing Group is the member of/Publishing partner of/Source content provider to:-